Cargando…

2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2

Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model, we explored the antiviral properties and immune-profile of a large panel of four highly stable and well-characterized MXenes - T...

Descripción completa

Detalles Bibliográficos
Autores principales: Unal, Mehmet Altay, Bayrakdar, Fatma, Fusco, Laura, Besbinar, Omur, Shuck, Christopher E., Yalcin, Süleyman, Erken, Mine Turktas, Ozkul, Aykut, Gurcan, Cansu, Panatli, Oguzhan, Summak, Gokce Yagmur, Gokce, Cemile, Orecchioni, Marco, Gazzi, Arianna, Vitale, Flavia, Somers, Julia, Demir, Emek, Yildiz, Serap Suzuk, Nazir, Hasan, Grivel, Jean-Charles, Bedognetti, Davide, Crisanti, Andrea, Akcali, Kamil Can, Gogotsi, Yury, Delogu, Lucia Gemma, Yilmazer, Açelya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969865/
https://www.ncbi.nlm.nih.gov/pubmed/33753982
http://dx.doi.org/10.1016/j.nantod.2021.101136
_version_ 1783666316345868288
author Unal, Mehmet Altay
Bayrakdar, Fatma
Fusco, Laura
Besbinar, Omur
Shuck, Christopher E.
Yalcin, Süleyman
Erken, Mine Turktas
Ozkul, Aykut
Gurcan, Cansu
Panatli, Oguzhan
Summak, Gokce Yagmur
Gokce, Cemile
Orecchioni, Marco
Gazzi, Arianna
Vitale, Flavia
Somers, Julia
Demir, Emek
Yildiz, Serap Suzuk
Nazir, Hasan
Grivel, Jean-Charles
Bedognetti, Davide
Crisanti, Andrea
Akcali, Kamil Can
Gogotsi, Yury
Delogu, Lucia Gemma
Yilmazer, Açelya
author_facet Unal, Mehmet Altay
Bayrakdar, Fatma
Fusco, Laura
Besbinar, Omur
Shuck, Christopher E.
Yalcin, Süleyman
Erken, Mine Turktas
Ozkul, Aykut
Gurcan, Cansu
Panatli, Oguzhan
Summak, Gokce Yagmur
Gokce, Cemile
Orecchioni, Marco
Gazzi, Arianna
Vitale, Flavia
Somers, Julia
Demir, Emek
Yildiz, Serap Suzuk
Nazir, Hasan
Grivel, Jean-Charles
Bedognetti, Davide
Crisanti, Andrea
Akcali, Kamil Can
Gogotsi, Yury
Delogu, Lucia Gemma
Yilmazer, Açelya
author_sort Unal, Mehmet Altay
collection PubMed
description Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model, we explored the antiviral properties and immune-profile of a large panel of four highly stable and well-characterized MXenes - Ti(3)C(2)T(x), Ta(4)C(3)T(x), Mo(2)Ti(2)C(3)T(x) and Nb(4)C(3)T(x). To start with antiviral assessment, we first selected and deeply analyzed four different SARS-CoV-2 genotypes, common in most countries and carrying the wild type or mutated spike protein. When inhibition of the viral infection was tested in vitro with four viral clades, Ti(3)C(2)T(x) in particular, was able to significantly reduce infection only in SARS-CoV-2/clade GR infected Vero E6 cells. This difference in the antiviral activity, among the four viral particles tested, highlights the importance of considering the viral genotypes and mutations while testing antiviral activity of potential drugs and nanomaterials. Among the other MXenes tested, Mo(2)Ti(2)C(3)T(x) also showed antiviral properties. Proteomic, functional annotation analysis and comparison to the already published SARS-CoV-2 protein interaction map revealed that MXene-treatment exerts specific inhibitory mechanisms. Envisaging future antiviral MXene-based drug nano-formulations and considering the central importance of the immune response to viral infections, the immune impact of MXenes was evaluated on human primary immune cells by flow cytometry and single-cell mass cytometry on 17 distinct immune subpopulations. Moreover, 40 secreted cytokines were analyzed by Luminex technology. MXene immune profiling revealed i) the excellent bio and immune compatibility of the material, as well as the ability of MXene ii) to inhibit monocytes and iii) to reduce the release of pro-inflammatory cytokines, suggesting an anti-inflammatory effect elicited by MXene. We here report a selection of MXenes and viral SARS-CoV-2 genotypes/mutations, a series of the computational, structural and molecular data depicting deeply the SARS-CoV-2 mechanism of inhibition, as well as high dimensional single-cell immune-MXene profiling. Taken together, our results provide a compendium of knowledge for new developments of MXene-based multi-functioning nanosystems as antivirals and immune-modulators.
format Online
Article
Text
id pubmed-7969865
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79698652021-03-18 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2 Unal, Mehmet Altay Bayrakdar, Fatma Fusco, Laura Besbinar, Omur Shuck, Christopher E. Yalcin, Süleyman Erken, Mine Turktas Ozkul, Aykut Gurcan, Cansu Panatli, Oguzhan Summak, Gokce Yagmur Gokce, Cemile Orecchioni, Marco Gazzi, Arianna Vitale, Flavia Somers, Julia Demir, Emek Yildiz, Serap Suzuk Nazir, Hasan Grivel, Jean-Charles Bedognetti, Davide Crisanti, Andrea Akcali, Kamil Can Gogotsi, Yury Delogu, Lucia Gemma Yilmazer, Açelya Nano Today Article Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model, we explored the antiviral properties and immune-profile of a large panel of four highly stable and well-characterized MXenes - Ti(3)C(2)T(x), Ta(4)C(3)T(x), Mo(2)Ti(2)C(3)T(x) and Nb(4)C(3)T(x). To start with antiviral assessment, we first selected and deeply analyzed four different SARS-CoV-2 genotypes, common in most countries and carrying the wild type or mutated spike protein. When inhibition of the viral infection was tested in vitro with four viral clades, Ti(3)C(2)T(x) in particular, was able to significantly reduce infection only in SARS-CoV-2/clade GR infected Vero E6 cells. This difference in the antiviral activity, among the four viral particles tested, highlights the importance of considering the viral genotypes and mutations while testing antiviral activity of potential drugs and nanomaterials. Among the other MXenes tested, Mo(2)Ti(2)C(3)T(x) also showed antiviral properties. Proteomic, functional annotation analysis and comparison to the already published SARS-CoV-2 protein interaction map revealed that MXene-treatment exerts specific inhibitory mechanisms. Envisaging future antiviral MXene-based drug nano-formulations and considering the central importance of the immune response to viral infections, the immune impact of MXenes was evaluated on human primary immune cells by flow cytometry and single-cell mass cytometry on 17 distinct immune subpopulations. Moreover, 40 secreted cytokines were analyzed by Luminex technology. MXene immune profiling revealed i) the excellent bio and immune compatibility of the material, as well as the ability of MXene ii) to inhibit monocytes and iii) to reduce the release of pro-inflammatory cytokines, suggesting an anti-inflammatory effect elicited by MXene. We here report a selection of MXenes and viral SARS-CoV-2 genotypes/mutations, a series of the computational, structural and molecular data depicting deeply the SARS-CoV-2 mechanism of inhibition, as well as high dimensional single-cell immune-MXene profiling. Taken together, our results provide a compendium of knowledge for new developments of MXene-based multi-functioning nanosystems as antivirals and immune-modulators. Elsevier Ltd. 2021-06 2021-03-18 /pmc/articles/PMC7969865/ /pubmed/33753982 http://dx.doi.org/10.1016/j.nantod.2021.101136 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Unal, Mehmet Altay
Bayrakdar, Fatma
Fusco, Laura
Besbinar, Omur
Shuck, Christopher E.
Yalcin, Süleyman
Erken, Mine Turktas
Ozkul, Aykut
Gurcan, Cansu
Panatli, Oguzhan
Summak, Gokce Yagmur
Gokce, Cemile
Orecchioni, Marco
Gazzi, Arianna
Vitale, Flavia
Somers, Julia
Demir, Emek
Yildiz, Serap Suzuk
Nazir, Hasan
Grivel, Jean-Charles
Bedognetti, Davide
Crisanti, Andrea
Akcali, Kamil Can
Gogotsi, Yury
Delogu, Lucia Gemma
Yilmazer, Açelya
2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
title 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
title_full 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
title_fullStr 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
title_full_unstemmed 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
title_short 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
title_sort 2d mxenes with antiviral and immunomodulatory properties: a pilot study against sars-cov-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969865/
https://www.ncbi.nlm.nih.gov/pubmed/33753982
http://dx.doi.org/10.1016/j.nantod.2021.101136
work_keys_str_mv AT unalmehmetaltay 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT bayrakdarfatma 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT fuscolaura 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT besbinaromur 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT shuckchristophere 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT yalcinsuleyman 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT erkenmineturktas 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT ozkulaykut 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT gurcancansu 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT panatlioguzhan 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT summakgokceyagmur 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT gokcecemile 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT orecchionimarco 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT gazziarianna 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT vitaleflavia 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT somersjulia 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT demiremek 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT yildizserapsuzuk 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT nazirhasan 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT griveljeancharles 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT bedognettidavide 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT crisantiandrea 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT akcalikamilcan 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT gogotsiyury 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT deloguluciagemma 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2
AT yilmazeracelya 2dmxeneswithantiviralandimmunomodulatorypropertiesapilotstudyagainstsarscov2